← Back to Search

Protein Supplement

Collagen Protein for Muscle Recovery

N/A

Waitlist Available

Research Sponsored by University of Central Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Males between the ages of 18-30 years old

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 days

Summary

This trial aims to investigate the difference between taking collagen protein and a placebo after doing exercises that damage muscles. The goal is to see how these two types of supplements affect muscle recovery after specific calf exercises.

Who is the study for?

This trial is for healthy males aged 18-30 who regularly engage in resistance training. They must not have allergies to bovine collagen or maltodextrin, and should pass health questionnaires (PAR-Q+ and HHQ) without any 'yes' responses indicating potential health issues.

What is being tested?

The study compares the effects of collagen protein with a placebo (maltodextrin) on muscle recovery after calf exercises that cause muscle damage. It aims to see if collagen helps muscles and tendons recover better than a non-active substance.

What are the potential side effects?

Since this trial involves common dietary supplements—collagen and maltodropex—the side effects are likely minimal but could include mild digestive discomfort or allergic reactions in those sensitive to the ingredients.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a male aged between 18 and 30.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Calf muscle thickness

Secondary study objectives

Achilles tendon thickness.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Placebo Group

Group I: CollagenExperimental Treatment1 Intervention

Collagen supplementation group will have 12 participants. They will perform various physical assessments that include pain scale, pain pressure threshold assessment, body composition, calf circumference measurements, muscle thickness measurements, Achilles tendon length and thickness measurements, myotonography of the calf, isometric force assessments during standing and seated plantarflexion positions, a heel raise test, and a standardized exercise routine focused on eccentric movements, targeting a leg chosen at random. Additionally, they will consume a daily dose of two 30-g amount of collagen peptides derived from bovine hide (commercially available as Vital Proteins or Peptan).

Group II: ControlActive Control1 Intervention

Control group (n=12) will receive no supplement. Control group participants will do all the assessments that the intervention participants are performing, except for the standardized exercise routine focused on the eccentric movements. Randomization will be performed via www.randomizer.org website.

Group III: PlaceboPlacebo Group1 Intervention

Placebo supplementation group will have 12 participants. They will perform various physical assessments that include pain scale, pain pressure threshold assessment, body composition, calf circumference measurements, muscle thickness measurements, Achilles tendon length and thickness measurements, myotonography of the calf, isometric force assessments during standing and seated plantarflexion positions, a heel raise test, and a standardized exercise routine focused on eccentric movements, targeting a leg chosen at random. Additionally, they will consume a daily dose of placebo (two 30 g of pure maltodextrin with no amino acids) mixed in 300 ml of orange Gatorade zero.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Collagen

2022

N/A

~260

0 / 1Eligibility criteria met